Stephane Bancel, chief executive of Moderna, and other executives in the US biotechnology company have been steadily selling off their stakes throughout the pandemic. Bloomberg
Stephane Bancel, chief executive of Moderna, and other executives in the US biotechnology company have been steadily selling off their stakes throughout the pandemic. Bloomberg
Billionaires: Moderna chief sells $1.74m worth of shares before vaccine filing
In our fortnightly roundup, Stephane Bancel’s net worth jumps to $3.1bn after offloading 19,000 shares, while French magnate Xavier Niel seeks consumer sector deals